𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation

✍ Scribed by A Gratwohl; J Hermans; JM Goldman; W Arcese; E Carreras; A Devergie; F Frassoni; G Gahrton; HJ Kolb; D Niederwieser; T Ruutu; JP Vernant; T de Witte; J Apperley

Book ID
117311236
Publisher
The Lancet
Year
1998
Tongue
English
Weight
86 KB
Volume
352
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Outcome of Chinese patients with chronic
Outcome of Chinese patients with chronic myeloid leukaemia (CML) underwent allogeneic bone-marrow transplantation (BMT)
✍ Lee, C.K.; Lie, A.K.W.; Liang, R.; Au, W.Y.; Chen, F.E.; Chim, C.S.; Kwong, Y.L. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 43 KB πŸ‘ 2 views

Clinical studies have shown that patients with chronic myeloid leukaemia (CML) treated with allogeneic bone-marrow transplantation (BMT) experience not only prolonged disease-free survival but also complete cure in some. Therefore, we followed a cohort of 81 Chinese patients who received allogeneic

Prognostic factors for patients with acu
Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation
✍ Thorsten Graef; Matthias Vaupel; Roland Fenk; Leilani Ruf; Fabian Zohren; Ulrich πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 1 views

## Abstract In this uni‐centre retrospective study, we studied 120 adults with acute myeloid leukaemia (AML) (__n__ = 88) and myelodysplastic syndrome (MDS) (__n__ = 32) who received first allogeneic HSCT to determine prognostic factors which are correlated with the outcome after myeloablative (MA)